BioAscent is attending and exhibiting at the RSC-BMCS/SCI Targeting Protein Degradation 4 conference on 15-16 October at Cranfield University, Bedford.

One of the most exciting new therapeutic modalities to emerge in the 21st century has been Targeted Protein Degradation (TPD). This meeting is targeted at academic and industrial scientists engaged in all aspects of research into the ubiquitin-proteasome pathway and those interested in broadening their knowledge in this rapidly expanding field.

The BioAscent team will be available to answer questions from delegates. If you’d like to arrange a meeting, please get in touch by emailing info@bioascent.com.

Find out more about the event here.